{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:29:48Z","timestamp":1790958588683,"version":"4.1.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03103-w","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T18:13:08Z","timestamp":1745604788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Integration of Synchronizing\u00a0In Silico,\u00a0In Vitro, and\u00a0In Vivo\u00a0Strategies for the Development of Antipsoriatic Apremilast-loaded Nanostructured Lipid Carrier Embedded in Hydrogel"],"prefix":"10.1208","volume":"26","author":[{"given":"Nikita","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneri","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavin","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1057-2566","authenticated-orcid":false,"given":"Pranav","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangrulkar","family":"Shubhada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umekar","family":"Milind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamla","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahavir Bhupal","family":"Chougule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"issue":"12","key":"3103_CR1","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.drudis.2020.09.023","volume":"25","author":"VK Rapalli","year":"2020","unstructured":"Rapalli VK, Waghule T, Gorantla S, Dubey SK, Saha RN, Singhvi G. Psoriasis: pathological mechanisms, current pharmacological therapies, and emerging drug delivery systems. Drug Discov Today. 2020;25(12):2212\u201326.","journal-title":"Drug Discov Today."},{"issue":"5","key":"3103_CR2","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1002\/ptr.6973","volume":"35","author":"N Dabholkar","year":"2021","unstructured":"Dabholkar N, Rapalli VK, Singhvi G. Potential herbal constituents for psoriasis treatment as protective and effective therapy. Phytotherapy Research. 2021;35(5):2429\u201344.","journal-title":"Phytotherapy Research."},{"key":"3103_CR3","doi-asserted-by":"publisher","first-page":"102442","DOI":"10.1016\/j.jddst.2021.102442","volume":"63","author":"VK Rapalli","year":"2021","unstructured":"Rapalli VK, Sharma S, Roy A, Alexander A, Singhvi G. Solid lipid nanocarriers embedded hydrogel for topical delivery of apremilast: In-vitro, ex-vivo, dermato pharmacokinetic and anti-psoriatic evaluation. J Drug Deliv Sci Technol. 2021;63:102442.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3103_CR4","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.biopha.2018.06.136","volume":"106","author":"VK Rapalli","year":"2018","unstructured":"Rapalli VK, Singhvi G, Dubey SK, Gupta G, Chellappan DK, Dua K. Emerging landscape in psoriasis management: From topical application to targeting biomolecules. Biomed and Pharmacother. 2018;106:707\u201313.","journal-title":"Biomed and Pharmacother."},{"key":"3103_CR5","first-page":"75","volume":"2","author":"G Singhvi","year":"2020","unstructured":"Singhvi G, Hejmady S, Rapalli VK, Dubey SK, Dubey S. Nanocarriers for topical delivery in psoriasis. Deliv Drugs: Expectations Realities of Multifunctional Drug Delivery Syst. 2020;2:75\u201396.","journal-title":"Deliv Drugs: Expectations Realities of Multifunctional Drug Delivery Syst"},{"issue":"8","key":"3103_CR6","first-page":"495","volume":"40","author":"T Zerilli","year":"2015","unstructured":"Zerilli T, Ocheretyaner E. Apremilast (Otezla): A new oral treatment for adults with psoriasis and psoriatic arthritis. P and T. 2015;40(8):495\u2013500.","journal-title":"P and T."},{"key":"3103_CR7","first-page":"105","volume":"8","author":"L Fala","year":"2015","unstructured":"Fala L. Otezla (Apremilast), an oral PDE-4 Inhibitor, receives FDA approval for the treatment of patients with active psoriatic arthritis and plaque psoriasis. Am Health Drug Benefits. 2015;8:105\u201310.","journal-title":"Am. Health Drug Benefits."},{"key":"3103_CR8","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1248\/cpb.c16-00519","volume":"64","author":"M Tang","year":"2016","unstructured":"Tang M, Hu P, Huang S, Zheng Q, Yu H, He Y. Development of an Extended-Release Formulation for Apremilast and Level An in Vitro-in Vivo Correlation Study in Beagle Dogs. Chem Pharm Bull. 2016;64:1607\u201315.","journal-title":"Chem. Pharm. Bull."},{"key":"3103_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.colsurfb.2016.03.026","volume":"143","author":"R Pireddu","year":"2016","unstructured":"Pireddu R, Caddeo C, Valenti D, Marongiu F, Scano A, Ennas G, et al. Diclofenac acid nanocrystals as an effective strategy to reduce in vivo skin inflammation by improving dermal drug bioavailability. Colloids Surf B. 2016;143:64\u201370.","journal-title":"Colloids Surf. B."},{"issue":"8","key":"3103_CR10","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1021\/acs.molpharmaceut.5b00961","volume":"13","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Wischke C, Mittal S, Mitra A, Schwendeman SP. Design of Controlled Release PLGA Microspheres for Hydrophobic fenretinide. Mol Pharm. 2016;13(8):2622\u201330.","journal-title":"Mol Pharm."},{"key":"3103_CR11","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.2147\/IJN.S195048","volume":"14","author":"MK Anwer","year":"2019","unstructured":"Anwer MK, Mohammad M, Ezzeldin E, Fatima F, Alalaiwe A, Iqbal M. Preparation of sustained release apremilast-loaded PLGA nanoparticles: In vitro characterization and in vivo pharmacokinetic study in rats. Int J Nanomedicine. 2019;14:1587\u201395.","journal-title":"Int J Nanomedicine."},{"issue":"3","key":"3103_CR12","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1007\/s13346-020-00809-1","volume":"11","author":"PK Parmar","year":"2021","unstructured":"Parmar PK, Bansal AK. Novel nanocrystal-based formulations of apremilast for improved topical delivery. Drug Deliv Transl Res. 2021;11(3):966\u201383.","journal-title":"Drug Deliv Transl Res."},{"issue":"2","key":"3103_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.5530\/ijpi.2021.2.41","volume":"11","author":"SS Mulleria","year":"2021","unstructured":"Mulleria SS, Marina K, Ghetia SM. Formulation, Optimization and in vitro Evaluation of Apremilast Nanoemulgel for Topical Delivery. Int J Pharm Investig. 2021;11(2):230\u20137.","journal-title":"Int J Pharm Investig."},{"issue":"6","key":"3103_CR14","doi-asserted-by":"publisher","first-page":"13905","DOI":"10.1111\/dth.13905","volume":"33","author":"T Waghule","year":"2020","unstructured":"Waghule T, Sankar S, Rapalli VK, Gorantla S, Dubey SK, Chellappan DK. Emerging role of nanocarriers based topical delivery of anti-fungal agents in combating growing fungal infections. Dermatol Ther. 2020;33(6):13905.","journal-title":"Dermatol Ther."},{"key":"3103_CR15","doi-asserted-by":"publisher","first-page":"105438","DOI":"10.1016\/j.ejps.2020.105438","volume":"152","author":"VK Rapalli","year":"2020","unstructured":"Rapalli VK, Kaul V, Waghule T, Gorantla S, Sharma S, Roy A. Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition. Eur J Pharm Sci. 2020;152:105438.","journal-title":"Eur J Pharm Sci"},{"issue":"13","key":"3103_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/polym14132633","volume":"14","author":"PPD Kondiah","year":"2022","unstructured":"Kondiah PPD, Rants\u2019o TA, Mdanda S, Mohlomi LM, Choonara YE. A Poly (Caprolactone)-Cellulose Nanocomposite Hydrogel for Transdermal Delivery of Hydrocortisone in Treating Psoriasis Vulgaris. Polymers. 2022;14(13):1\u201323.","journal-title":"Polymers"},{"issue":"3","key":"3103_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s13346-016-0291-1","volume":"6","author":"U Nagaich","year":"2016","unstructured":"Nagaich U, Gulati N. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization. Drug Deliv Transl Res. 2016;6(3):289\u201398.","journal-title":"Drug Deliv Transl Res"},{"issue":"2","key":"3103_CR18","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ijpharm.2015.09.054","volume":"495","author":"JS Baek","year":"2015","unstructured":"Baek JS, Pham CV, Myung CS, Cho CW. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers. Int J Pharm. 2015;495(2):701\u20139.","journal-title":"Int J Pharm."},{"key":"3103_CR19","doi-asserted-by":"publisher","first-page":"118310","DOI":"10.1016\/j.saa.2020.118310","volume":"235","author":"A Mahmood","year":"2020","unstructured":"Mahmood A, Rapalli VK, Waghule T, Gorantla S, Singhvi G. UV spectrophotometric method for simultaneous estimation of betamethasone valerate and tazarotene with absorption factor method: Application for in-vitro and ex-vivo characterization of lipidic nanocarriers for topical delivery. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2020;235:118310.","journal-title":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"},{"issue":"4","key":"3103_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12551-016-0218-6","volume":"8","author":"J Stetefeld","year":"2016","unstructured":"Stetefeld J, McKenna SA, Patel TR. Dynamic light scattering: a practical guide and applications in biomedical sciences. Biophys Rev. 2016;8(4):409\u201327.","journal-title":"Biophys Rev"},{"issue":"2","key":"3103_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s13204-015-0434-6","volume":"6","author":"R Velmurugan","year":"2016","unstructured":"Velmurugan R, Selvamuthukumar S. Development and optimization of ifosfamide nanostructured lipid carriers for oral delivery using response surface methodology. Appl Nanosci. 2016;6(2):159\u201373.","journal-title":"Appl Nanosci"},{"key":"3103_CR22","unstructured":"FDA dissolution database. https:\/\/wwwa.accessdata.fda.gov\/scripts\/cder\/dissolution\/dsp_SearchResults.cfm. Accessed\u00a08-8-2022."},{"issue":"1","key":"3103_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0378-5173(95)00123-Z","volume":"125","author":"VP Shah","year":"1995","unstructured":"Shah VP, Noory A, Noory C, Mccullough B, Clarke S, Everett R. In vitro dissolution of sparingly water-soluble drug dosage forms. Int J Pharma. 1995;125(1):99\u2013106.","journal-title":"Int J Pharma."},{"issue":"3","key":"3103_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.14227\/DT160309P14","volume":"16","author":"H Jogia","year":"2009","unstructured":"Jogia H, Mehta T, Patel M. Evaluation of dissolution media containing a novel synthetic surfactant by in vitro testing of BCS class II drugs. Dissolu Technol. 2009;16(3):14\u20139.","journal-title":"Dissolu Technol"},{"issue":"9","key":"3103_CR25","first-page":"1","volume":"5","author":"S Brito Raj","year":"2019","unstructured":"Brito Raj S, Chandrasekhar KB, Reddy KB. Formulation, in-vitro and in-vivo pharmacokinetic evaluation of simvastatin nanostructured lipid carrier loaded transdermal drug delivery system. Futur J Pharm Sci. 2019;5(9):1\u201314.","journal-title":"Futur J Pharm Sci"},{"issue":"2","key":"3103_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/pr7020096","volume":"7","author":"D Laky","year":"2019","unstructured":"Laky D, Xu S, Rodriguez JS, Vaidyaraman S, Munoz SG, Laird C. An optimization-based framework to define the probabilistic design space of pharmaceutical processes with model uncertainty. Processes. 2019;7(2):96.","journal-title":"Processes."},{"issue":"3","key":"3103_CR27","doi-asserted-by":"publisher","first-page":"446","DOI":"10.34172\/apb.2023.056","volume":"13","author":"S Khan","year":"2023","unstructured":"Khan S, Sharma A, Jain V. An overview of nanostructured lipid carriers and its application in drug delivery through different routes. Adv Pharm Bull. 2023;13(3):446\u201360.","journal-title":"Adv Pharm Bull."},{"issue":"5","key":"3103_CR28","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1080\/03639045.2019.1576722","volume":"45","author":"P Sathe","year":"2019","unstructured":"Sathe P, Saka R, Kommineni N, Raza K, Khan W. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model. Drug Dev Ind Pharm. 2019;45(5):826\u201338.","journal-title":"Drug Dev Ind Pharm."},{"issue":"12","key":"3103_CR29","first-page":"5185","volume":"17","author":"M Sabzichi","year":"2016","unstructured":"Sabzichi M, Mohammadian J, Khosroushahi AY, Bazzaz R, Hamishehkar H. Folate-targeted nanostructured lipid carriers (NLCs) Enhance (Letrozol) Efficacy in MCF-7 Breast Cancer Cells. Asian Pac J of Cancer Prev. 2016;17(12):5185\u20138.","journal-title":"Asian Pac J of Cancer Prev."},{"issue":"2","key":"3103_CR30","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3390\/pharmaceutics15020537","volume":"15","author":"B Morakul","year":"2023","unstructured":"Morakul B, Junyaprasert VB, Sakchaisri K, Teeranachaideekul V. Cannabidiol-Loaded Nanostructured Lipid Carriers (NLCs) for dermal delivery: enhancement of photostability, cell viability, and anti-inflammatory activity. Pharmaceutics. 2023;15(2):537.","journal-title":"Pharmaceutics"},{"issue":"8","key":"3103_CR31","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/pharmaceutics11080397","volume":"11","author":"PA Makoni","year":"2019","unstructured":"Makoni PA, Kasongo KW, Walker RB. Short term stability testing of efavirenz-loaded solid lipid nanoparticle (SLN) and nanostructured lipid carrier (NLC) dispersions. Pharmaceutics. 2019;11(8):397.","journal-title":"Pharmaceutics"},{"issue":"3","key":"3103_CR32","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3390\/ma16031212","volume":"16","author":"I Andreana","year":"2023","unstructured":"Andreana I, Bincoletto V, Manzoli M, Roda F, Giarraputo V, Milla P. Freeze drying of polymer nanoparticles and liposomes exploiting different saccharide-based approaches. Materials. 2023;16(3):1212.","journal-title":"Materials"},{"key":"3103_CR33","doi-asserted-by":"publisher","first-page":"104794","DOI":"10.1016\/j.chemphyslip.2019.104794","volume":"224","author":"MK Chauhan","year":"2019","unstructured":"Chauhan MK, Sharma PK. Optimization and characterization of rivastigmine nanolipid carrier loaded transdermal patches for the treatment of dementia. Chem Phys Lipids. 2019;224:104794.","journal-title":"Chem Phys Lipids"},{"key":"3103_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejpb.2019.03.017","volume":"139","author":"C Tetyczka","year":"2019","unstructured":"Tetyczka C, Hodzic A, Kriechbaum M, Juraic K, Spirk C, Hartl S. Comprehensive characterization of nanostructured lipid carriers using laboratory and synchrotron X-ray scattering and diffraction. Eur J Pharm Biopharma. 2019;139:153\u201360.","journal-title":"Eur J Pharm Biopharma."},{"key":"3103_CR35","doi-asserted-by":"crossref","unstructured":"Salman M, Owida H, Njoroge W, Siddiqui Rahim, Ambedkar B. Development and evaluation of cationic nanostructured lipid carriers for ophthalmic drug delivery of besifloxacin. J Drug Deliv Sci Technol. 2020;55:101496.","DOI":"10.1016\/j.jddst.2019.101496"},{"key":"3103_CR36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jddst.2019.04.026","volume":"52","author":"T Waghule","year":"2019","unstructured":"Waghule T, Rapalli VK, Singhvi G, Manchanda P, Hans N, Dubey SK. Voriconazole loaded nanostructured lipid carriers based topical delivery system: QbD based designing, characterization, in-vitro and ex-vivo evaluation. J Drug Deliv Sci Technol. 2019;52:303\u201315.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3103_CR37","doi-asserted-by":"crossref","unstructured":"Press D. Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil. 2016; 11:5067\u201377.","DOI":"10.2147\/IJN.S117511"},{"issue":"1","key":"3103_CR38","first-page":"61","volume":"10","author":"HA Ranpise","year":"2020","unstructured":"Ranpise HA, Gujar KN, Pawar SC, Awasthi R, Dua K, Mathure D. Formulation, Optimization, and Evaluation of Ketoconazole Loaded Nanostructured Lipid Carrier Gel for Topical Delivery. Drug Deliv Lett. 2020;10(1):61\u201371.","journal-title":"Drug Deliv Lett."},{"key":"3103_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2021.713616","volume":"12","author":"NK Garg","year":"2021","unstructured":"Garg NK, Tandel N, Bhadada SK, Tyagi RK. Nanostructured Lipid Carrier \u2013 Mediated Transdermal Delivery of Aceclofenac Hydrogel Present an Effective Therapeutic Approach for Inflammatory Diseases. Front Pharmacol. 2021;12:1\u201318.","journal-title":"Front Pharmacol."},{"key":"3103_CR40","first-page":"7","volume":"33","author":"M Koland","year":"2021","unstructured":"Koland M. Topical Delivery of Apremilast Loaded Nanostructured Lipid Carrier Based Hydrogel for Psoriasis Therapy. J Pharm Reser Int. 2021;33:7\u201320.","journal-title":"J Pharm Reser Int."},{"key":"3103_CR41","doi-asserted-by":"crossref","unstructured":"Mohammed SS. Evaluation Lycopene effect as a monotherapy and add on to Clobetasol on Spleen inflammatory biomarkers and spleen index in IMQ induced psoriasis like inflammation in mice. Res Square. 2023;4:86\u201391.","DOI":"10.21203\/rs.3.rs-2735724\/v1"},{"issue":"2","key":"3103_CR42","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00709-015-0829-y","volume":"253","author":"N Arora","year":"2016","unstructured":"Arora N, Shah K, Pandey-Rai S. Inhibition of imiquimod-induced psoriasis-like dermatitis in mice by herbal extracts from some Indian medicinal plants. Protoplasma. 2016;253(2):503\u201315.","journal-title":"Protoplasma."},{"issue":"3","key":"3103_CR43","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/cei.13363","volume":"198","author":"C Liu","year":"2019","unstructured":"Liu C, Liu H, Lu C, Deng J, Yan Y, Chen H. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model. Clin Exp Immunol. 2019;198(3):403\u201315.","journal-title":"Clin Exp Immunol."},{"issue":"2","key":"3103_CR44","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s12668-025-01829-2","volume":"15","author":"R Kharwade","year":"2025","unstructured":"Kharwade R, Mahajan N, Ali S, Chakolkar M, Jain S, More S. Development and Characterization of Genistein-Loaded Silver Nanoparticles for the Induction of Apoptosis on Human Hepatocellular Carcinoma Cell Lines. Bionanoscience. 2025;15(2):227.","journal-title":"Bionanoscience."},{"issue":"3","key":"3103_CR45","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3390\/pharmaceutics14030584","volume":"14","author":"AH Asif","year":"2022","unstructured":"Asif AH, Desu PK, Alavala RR, Rao GSNK, Sreeharsha N, Meravanige G. Development, statistical optimization and characterization of fluvastatin loaded solid lipid nanoparticles: a 32 factorial design approach. Pharmaceutics. 2022;14(3):584.","journal-title":"Pharmaceutics"},{"issue":"5","key":"3103_CR46","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1208\/s12249-016-0621-0","volume":"18","author":"HR Kelidari","year":"2017","unstructured":"Kelidari HR, Saeedi M, Akbari J, Morteza-semnani K, Valizadeh H, Maniruzzaman M. Development and optimisation of spironolactone nanoparticles for enhanced dissolution rates and stability. AAPS Pharm SciTech. 2017;18(5):1469\u201374.","journal-title":"AAPS Pharm SciTech."},{"key":"3103_CR47","doi-asserted-by":"crossref","unstructured":"Emami J, Rezazadeh M, Varshosaz J, Tabbakhian M, Aslani A. Formulation of LDL targeted nanostructured lipid carriers loaded with paclitaxel: A detailed study of preparation, freeze drying condition, and in vitro cytotoxicity. J Nanomater. 2012;1-10.","DOI":"10.1155\/2012\/358782"},{"issue":"1","key":"3103_CR48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejps.2012.05.010","volume":"47","author":"S Das","year":"2012","unstructured":"Das S, Ng WK, Tan RBH. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs. Eur J Pharm Sci. 2012;47(1):139\u201351.","journal-title":"Eur J Pharm Sci."},{"issue":"6","key":"3103_CR49","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/20415990.2024.2342771","volume":"15","author":"HP Nijhawan","year":"2024","unstructured":"Nijhawan HP, Prabhakar B, Yadav KS. Central composite design augmented quality-by-design-based systematic formulation of erlotinib hydrochloride-loaded chitosan-poly (lactic-co-glycolic acid) nanoparticles. Ther Deliv. 2024;15(6):427\u201347.","journal-title":"Ther Deliv."},{"key":"3103_CR50","doi-asserted-by":"crossref","unstructured":"Agrawal M, Saraf S, Pradhan M, Patel RJ, Singhvi G, Ajazuddin. Design and optimization of curcumin loaded nano lipid carrier system using Box-Behnken design. Biomed Pharmacother. 2021;141:111919.","DOI":"10.1016\/j.biopha.2021.111919"},{"key":"3103_CR51","doi-asserted-by":"publisher","first-page":"113734","DOI":"10.1016\/j.molliq.2020.113734","volume":"316","author":"C Houacine","year":"2020","unstructured":"Houacine C, Adams D, Singh Kamalinder K. Impact of liquid lipid on development and stability of trimyristin nanostructured lipid carriers for oral delivery of resveratrol. J Mol Liq. 2020;316:113734.","journal-title":"J Mol Liq"},{"issue":"1","key":"3103_CR52","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1208\/s12249-011-9733-8","volume":"13","author":"A Chinsriwongkul","year":"2012","unstructured":"Chinsriwongkul A, Chareanputtakhun P, Ngawhirunpat T. Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug. AAPS Pharm SciTech. 2012;13(1):150\u20138.","journal-title":"AAPS Pharm SciTech."},{"issue":"2","key":"3103_CR53","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.bfopcu.2015.10.001","volume":"53","author":"B Gaba","year":"2015","unstructured":"Gaba B, Fazil M, Khan S, Ali A, Baboota S, Ali J. Nanostructured lipid carrier system for topical delivery of terbinafine hydrochloride. Bull Faculty Pharm, Cairo Univ. 2015;53(2):147\u201359.","journal-title":"Bull Faculty Pharm, Cairo Univ"},{"key":"3103_CR54","doi-asserted-by":"crossref","unstructured":"Mudalige T, Qu H, Van Haute D, Ansar SM, Paredes A, Ingle T. Characterization of nanomaterials: tools and challenges. Nanomaterials for Food Applications. 2019;313\u201353.","DOI":"10.1016\/B978-0-12-814130-4.00011-7"},{"key":"3103_CR55","doi-asserted-by":"publisher","first-page":"108836","DOI":"10.1016\/j.lwt.2019.108836","volume":"119","author":"S Bashiri","year":"2020","unstructured":"Bashiri S, Ghanbarzadeh B, Ayaseh A, Dehghannya J, Ehsani A. Preparation and characterization of chitosan-coated nanostructured lipid carriers (CH-NLC) containing cinnamon essential oil for enriching milk and antioxidant activity. LWT. 2020;119:108836.","journal-title":"LWT"},{"issue":"11","key":"3103_CR56","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1021\/acs.molpharmaceut.6b00586","volume":"13","author":"A Khan","year":"2016","unstructured":"Khan A, Imam SS, Aqil M, Ahad A, Sultana Y, Ali A. Brain Targeting of Temozolomide via the Intranasal Route Using Lipid-Based Nanoparticles: Brain Pharmacokinetic and Scintigraphy Analyses. Mol Pharm. 2016;13(11):3773\u201382.","journal-title":"Mol Pharm"},{"issue":"4","key":"3103_CR57","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3109\/10717544.2014.943337","volume":"23","author":"SS Salunkhe","year":"2016","unstructured":"Salunkhe SS, Bhatia NM, Bhatia MS. Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain. Drug Deliv. 2016;23(4):1306\u201316.","journal-title":"Drug Deliv"},{"key":"3103_CR58","doi-asserted-by":"publisher","first-page":"121050","DOI":"10.1016\/j.ijpharm.2021.121050","volume":"607","author":"D Gadhave","year":"2021","unstructured":"Gadhave D, Tupe S, Tagalpallewar A, Gorain B, Choudhury H, Kokare C. Nose-to-brain delivery of amisulpride-loaded lipid-based poloxamer-gellan gum nanoemulgel: In vitro and in vivo pharmacological studies. Int J Pharm. 2021;607:121050.","journal-title":"Int J Pharm"},{"issue":"2","key":"3103_CR59","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s13204-018-0909-3","volume":"9","author":"D Gadhave","year":"2019","unstructured":"Gadhave D, Choudhury H, Kokare C. Neutropenia and leukopenia protective intranasal olanzapine-loaded lipid-based nanocarriers engineered for brain delivery. Appl Nanosci. 2019;9(2):151\u201368.","journal-title":"Appl Nanosci"},{"issue":"6","key":"3103_CR60","first-page":"1912","volume":"23","author":"P Kaur","year":"2016","unstructured":"Kaur P, Garg T, Rath G, Murthy RS, Goyal AK. Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box-Behnken design. Drug Deliv. 2016;23(6):1912\u201325.","journal-title":"Drug Deliv."},{"issue":"1","key":"3103_CR61","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejps.2012.04.013","volume":"47","author":"M Fazil","year":"2012","unstructured":"Fazil M, Md S, Haque S, Kumar MN, Baboota S, Sahni JK. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. Eur J Pharm Sci. 2012;47(1):6\u201315.","journal-title":"Eur J Pharm Sci."},{"key":"3103_CR62","doi-asserted-by":"crossref","unstructured":"Sun M, Nie S, Pan X, Zhang R, Fan Z, Wang S. Quercetin-nanostructured lipid carriers: Characteristics and anti-breast cancer activities in vitro. Colloids Surf B Bio interfaces.2014;113:15\u201324.","DOI":"10.1016\/j.colsurfb.2013.08.032"},{"issue":"1\u20132","key":"3103_CR63","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ijpharm.2011.05.044","volume":"415","author":"R Tiwari","year":"2011","unstructured":"Tiwari R, Pathak K. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: Comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int J Pharm. 2011;415(1\u20132):232\u201343.","journal-title":"Int J Pharm."},{"issue":"10","key":"3103_CR64","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.3390\/pharmaceutics15102403","volume":"15","author":"M Silva-Abreu","year":"2023","unstructured":"Silva-Abreu M, Sosa L, Espinoza LC, Fabrega MJ, Rodriguez-Lagunas MJ, Mallandrich M. Efficacy of Apremilast Gels in Mouse Model of Imiquimod-Induced Psoriasis Skin Inflammation. Pharmaceutics. 2023;15(10):2403\u201330.","journal-title":"Pharmaceutics."},{"issue":"2","key":"3103_CR65","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/pharmaceutics11020097","volume":"11","author":"AA Khan","year":"2019","unstructured":"Khan AA, Mudassir J, Akhtar S, Murugaiyah V, Darwis Y. Freeze-dried lopinavir-loaded nanostructured lipid carriers for enhanced cellular uptake and bioavailability: Statistical optimization, in vitro and in vivo evaluations. Pharmaceutics. 2019;11(2):97.","journal-title":"Pharmaceutics."},{"key":"3103_CR66","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2147\/IJN.S402447","volume":"18","author":"MK Shehata","year":"2023","unstructured":"Shehata MK, Ismail AA, Kamel MA. Nose to brain delivery of astaxanthin-loaded nanostructured lipid carriers in rat model of alzheimer\u2019s disease: preparation, in vitro and in vivo evaluation. Int J Nanomed. 2023;18:1631\u201358.","journal-title":"Int J Nanomed"},{"key":"3103_CR67","doi-asserted-by":"crossref","unstructured":"Xia H jian, Zhang Z hai, Jin X, Hu Q, Chen X yun, Jia X bin. A novel drug-phospholipid complex enriched with micelles: preparation and evaluation in vitro and in vivo. Int J Nanomedicine.2013;8:545\u201354.","DOI":"10.2147\/IJN.S39526"},{"issue":"1","key":"3103_CR68","first-page":"23","volume":"19","author":"R Thatipamula","year":"2011","unstructured":"Thatipamula R, Palem C, Gannu R, Mudragada S, Yamsani M. Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers. Daru. 2011;19(1):23\u201332.","journal-title":"Daru"},{"key":"3103_CR69","doi-asserted-by":"publisher","first-page":"6135","DOI":"10.2147\/IJN.S205295","volume":"14","author":"S Gao","year":"2019","unstructured":"Gao S, Tian B, Han J, Zhang J, Shi Y, Lv Q. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema. Int J Nanomed. 2019;14:6135\u201350.","journal-title":"Int J Nanomed"},{"key":"3103_CR70","doi-asserted-by":"publisher","first-page":"111919","DOI":"10.1016\/j.biopha.2021.111919","volume":"141","author":"M Agrawal","year":"2021","unstructured":"Agrawal M, Saraf S, Pradhan M, Patel RJ, Singhvi G. Biomedicine & Pharmacotherapy Design and optimization of curcumin loaded nano lipid carrier system using Box-Behnken design. Biomed Pharmacotherapy. 2021;141:111919.","journal-title":"Biomed Pharmacotherapy"},{"key":"3103_CR71","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.2147\/IJN.S45313","volume":"8","author":"HS Rahman","year":"2013","unstructured":"Rahman HS, Rasedee A, How CW, Abdul AB, Zeenathul NA, Othman HH. Zerumbone-loaded nanostructured lipid carriers: Preparation, characterization, and antileukemic effect. Int J Nanomed. 2013;8:2769\u201381.","journal-title":"Int J Nanomed"},{"key":"3103_CR72","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jconrel.2020.02.020","volume":"321","author":"M Agrawal","year":"2020","unstructured":"Agrawal M, Saraf S, Saraf S, Dubey SK, Puri A, Patel RJ, et al. Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting. J Control Release. 2020;321:372\u2013415.","journal-title":"J Control Release"},{"issue":"1\u20132","key":"3103_CR73","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijpharm.2010.05.005","volume":"394","author":"CY Zhuang","year":"2010","unstructured":"Zhuang CY, Li N, Wang M, Zhang XN, Pan WS, Peng JJ. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm. 2010;394(1\u20132):179\u201385.","journal-title":"Int J Pharm."},{"key":"3103_CR74","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.2147\/IJN.S168148","volume":"13","author":"MA Abourehab","year":"2018","unstructured":"Abourehab MA, Ahmed OA, Balata GF, Almalki WH. Self-assembled biodegradable polymeric micelles to improve dapoxetine delivery across the blood-brain barrier. Int J Nanomedicine. 2018;13:3679\u201387.","journal-title":"Int J Nanomedicine"},{"issue":"4","key":"3103_CR75","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3109\/10717544.2013.859186","volume":"22","author":"KV Nikumbh","year":"2015","unstructured":"Nikumbh KV, Sevankar SG, Patil MP. Formulation development, in vitro and in vivo evaluation of microemulsion-based gel loaded with ketoprofen. Drug Deliv. 2015;22(4):509\u201315.","journal-title":"Drug Deliv"},{"issue":"7","key":"3103_CR76","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3390\/gels9070515","volume":"9","author":"M Alam","year":"2023","unstructured":"Alam M, Rizwanullah M, Mir SR, Amin S. Statistically optimized tacrolimus and thymoquinone co-loaded nanostructured lipid carriers gel for improved topical treatment of psoriasis. Gels. 2023;9(7):515.","journal-title":"Gels"},{"issue":"2","key":"3103_CR77","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2174\/2211738506666180523112513","volume":"6","author":"N Kaur","year":"2018","unstructured":"Kaur N, Sharma K, Bedi N. Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis. Pharm Nanotechnol. 2018;6(2):133\u201343.","journal-title":"Pharm Nanotechnol"},{"key":"3103_CR78","doi-asserted-by":"publisher","first-page":"102168","DOI":"10.1016\/j.jddst.2020.102168","volume":"61","author":"M Pradhan","year":"2021","unstructured":"Pradhan M, Alexander A, Singh MR, Singh D, Saraf S, Saraf S, et al. Statistically optimized calcipotriol fused nanostructured lipid carriers for effectual topical treatment of psoriasis. J Drug Deliv Sci Technol. 2021;61:102168.","journal-title":"J Drug Deliv Sci Technol."},{"issue":"9","key":"3103_CR79","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L Van der Fits","year":"2009","unstructured":"Van der Fits L, Mourits S, Voerman JSA, Kant M, Boon L, Laman JD, et al. Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23\/IL-17 Axis. J Immunol. 2009;182(9):5836\u201345.","journal-title":"J Immunol."},{"issue":"9","key":"3103_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics12090789","volume":"12","author":"M Jabeen","year":"2020","unstructured":"Jabeen M, Boisgard AS, Danoy A, El Kholti N, Salvi JP, Boulieu R, et al. Advanced characterization of imiquimod-induced psoriasis-like mouse model. Pharmaceutics. 2020;12(9):1\u201318.","journal-title":"Pharmaceutics"},{"issue":"5","key":"3103_CR81","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1007\/s11033-021-06445-3","volume":"48","author":"A Smajlovic","year":"2021","unstructured":"Smajlovic A, Haveric A, Alic A, Hadzic M, Smajlovic A, Mujezinovic I, et al. Molecular and histopathological profiling of imiquimod induced dermatosis in Swiss Wistar rats: contribution to the rat model for novel anti-psoriasis treatments. Mol Biol Rep. 2021;48(5):4295\u2013303.","journal-title":"Mol Biol Rep"},{"issue":"12","key":"3103_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph13120484","volume":"13","author":"P Sarango-Granda","year":"2020","unstructured":"Sarango-Granda P, Silva-Abreu M, Calpena AC, Halbaut L, Fabrega MJ, Rodriguez-Lagunas MJ, et al. Apremilast microemulsion as topical therapy for local inflammation: Design, characterization and efficacy evaluation. Pharmaceuticals. 2020;13(12):1\u201325.","journal-title":"Pharmaceuticals"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03103-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03103-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03103-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T17:02:51Z","timestamp":1751907771000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03103-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":82,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["3103"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03103-w","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"21 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No humans were utilized in this research work. The caution and use of laboratory animals were conducted in according with all institution and national guidelines. The study protocol number was (MPC\/IAEC\/08\/2022) and Protocol number (853\/IAEC\/2023 -\u200924\/27).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}},{"value":"The permission to publish has been granted by each author.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}],"article-number":"115"}}